Repligen Corp
NASDAQ:RGEN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
119.79
208.42
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Repligen Corp
Wall Street
Price Targets
RGEN Price Targets Summary
Repligen Corp
According to Wall Street analysts, the average 1-year price target for
RGEN
is 196.48 USD
with a low forecast of 161.6 USD and a high forecast of 236.25 USD.
RGEN Last Price Targets
Repligen Corp
The latest public price target was made on Nov 12, 2024 by
Paul Knight
from
KeyBanc
,
who expects
RGEN
stock to
rise by 42%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Paul Knight
KeyBanc
|
220
USD
Upside 42% |
1 month ago
Nov 12, 2024
|
KeyBanc Reiterates Overweight Rating on Repligen (RGEN)
StreetInsider
|
Elizabeth Garcia
UBS
|
185
USD
Upside 19% |
5 months ago
Jul 31, 2024
|
These Analysts Revise Their Forecasts On Repligen Following Q2 Results
Benzinga
|
Rachel Vatnsdal
J.P. Morgan
|
200
USD
Upside 29% |
5 months ago
Jul 31, 2024
|
These Analysts Revise Their Forecasts On Repligen Following Q2 Results
Benzinga
|
Justin Bowers
Deutsche Bank
|
155
USD
Upside 0% |
6 months ago
Jun 26, 2024
|
Deutsche Bank Upgrades Repligen (RGEN) to Buy
StreetInsider
|
Daniel Arias
Stifel Nicolaus
|
207
USD
Upside 34% |
6 months ago
Jun 21, 2024
|
Stifel Out Positive on Repligen (RGEN): 'current levels seem as though they will have proven to be good ones'
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is RGEN's stock price target?
Price Target
196.48
USD
According to Wall Street analysts, the average 1-year price target for
RGEN
is 196.48 USD
with a low forecast of 161.6 USD and a high forecast of 236.25 USD.
What is Repligen Corp's Revenue forecast?
Projected CAGR
11%
For the last 8 years the
compound annual growth rate for
Repligen Corp's revenue is
29%.
The projected
CAGR
for the next 4 years is
11%.
What is Repligen Corp's Operating Income forecast?
Projected CAGR
26%
For the last 8 years the
compound annual growth rate for
Repligen Corp's operating income is
22%.
The projected
CAGR
for the next 4 years is
26%.
What is Repligen Corp's Net Income forecast?
Projected CAGR
44%
For the last 8 years the
compound annual growth rate for
Repligen Corp's net income is
21%.
The projected
CAGR
for the next 4 years is
44%.
You don't have any saved screeners yet
